P3 Health Partners Inc.
NASDAQ:PIII
8.86 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 370.686 | 362.124 | 379.157 | 388.488 | 346.861 | 288.351 | 329.086 | 302.077 | 258.2 | 248.26 | 269.454 | 273.544 | 490,604.623 | 156.52 | 151.419 | 151.298 | 130.399 | 128.841 | 116.864 | 114.959 |
| Cost of Revenue
| 768.767 | 0 | 365.171 | 403.596 | 389.313 | 300.941 | 324.051 | 307.11 | 291.181 | 276.591 | 267.448 | 287.573 | 668.066 | 161.328 | 150.381 | 146.625 | 136.244 | 127.016 | 105.778 | 115.464 |
| Gross Profit
| -398.081 | 362.124 | 13.986 | -15.108 | -42.452 | -12.59 | 5.035 | -5.033 | -32.981 | -28.331 | 2.006 | -14.028 | 489,936.556 | -4.808 | 1.038 | 4.673 | -5.845 | 1.825 | 11.087 | -0.506 |
| Gross Profit Ratio
| -1.074 | 1 | 0.037 | -0.039 | -0.122 | -0.044 | 0.015 | -0.017 | -0.128 | -0.114 | 0.007 | -0.051 | 0.999 | -0.031 | 0.007 | 0.031 | -0.045 | 0.014 | 0.095 | -0.004 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 31.366 | 27.219 | 26.61 | 27.401 | 24.431 | 33.065 | 27.223 | 37.643 | 39.7 | 37.863 | 41.098 | 38.599 | 53,336.455 | 20.434 | 18.391 | 15.059 | 16.617 | 13.743 | 11.769 | 11.262 |
| Selling & Marketing Expenses
| 0.461 | 0.134 | 0.414 | 0.322 | 0.721 | 0.654 | 0.857 | 1.001 | 1.7 | 1.12 | 1.408 | 0.865 | 1,501.516 | 0.491 | 0.357 | 0.27 | 0.872 | 0.279 | 0.149 | 0.203 |
| SG&A
| 31.827 | 27.353 | 27.024 | 27.723 | 25.152 | 33.719 | 28.08 | 38.644 | 41.4 | 38.982 | 42.506 | 39.464 | 54,837.971 | 20.925 | 18.747 | 15.329 | 17.488 | 14.022 | 11.918 | 11.465 |
| Other Expenses
| 477.362 | 441.761 | 18.296 | -1 | 3.344 | 0.19 | -0.741 | 312.25 | 289.9 | 269.29 | 1.49 | 286.248 | 464,293.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 509.189 | 469.114 | 45.32 | 28.723 | 21.808 | 322.171 | 350.119 | 350.894 | 331.3 | 308.272 | 330.185 | 325.712 | 519,131.75 | 184.644 | 170.857 | 164.286 | 1.274 | 15.34 | 121.527 | 5.624 |
| Operating Income
| -138.503 | -106.99 | -31.334 | -43.831 | -64.26 | -33.82 | -21.033 | -48.817 | -536.5 | -60.012 | -912.187 | -52.168 | 60.55 | -28.124 | -19.438 | -12.988 | -4.281 | -13.515 | -4.663 | -6.13 |
| Operating Income Ratio
| -0.374 | -0.295 | -0.083 | -0.113 | -0.185 | -0.117 | -0.064 | -0.162 | -2.078 | -0.242 | -3.385 | -0.191 | 0 | -0.18 | -0.128 | -0.086 | -0.033 | -0.105 | -0.04 | -0.053 |
| Total Other Income Expenses Net
| 14.307 | 0.535 | 3.528 | -3.703 | -3.08 | -3.057 | -6.323 | -3.341 | 6.077 | -5.318 | 9.081 | -8.622 | -82.621 | -3.931 | -3.493 | -11.662 | 4.054 | -2.317 | -2.3 | -2.261 |
| Income Before Tax
| -124.196 | -106.455 | -27.806 | -47.534 | -67.34 | -36.877 | -27.356 | -52.158 | -530.5 | -65.329 | -903.106 | -60.79 | -31,329.869 | -34.168 | -24.968 | -24.651 | -0.227 | -15.831 | -6.963 | -8.391 |
| Income Before Tax Ratio
| -0.335 | -0.294 | -0.073 | -0.122 | -0.194 | -0.128 | -0.083 | -0.173 | -2.055 | -0.263 | -3.352 | -0.222 | -0.064 | -0.218 | -0.165 | -0.163 | -0.002 | -0.123 | -0.06 | -0.073 |
| Income Tax Expense
| 4.952 | -3.605 | 0.968 | 2.072 | 1.767 | 0.412 | 0.226 | 0.29 | 1.9 | -51.406 | -746.022 | -47.452 | -13.634 | 3.931 | 10.026 | 2.124 | 3.45 | 0.876 | -2.775 | -1.551 |
| Net Income
| -224.372 | -46.512 | -12.02 | -18.7 | -25.462 | -13.296 | -9.816 | -9.199 | -94.026 | -11.173 | -154.35 | -10.577 | 76.088 | -32.054 | -29.464 | -24.651 | -3.677 | -16.707 | -4.188 | -6.84 |
| Net Income Ratio
| -0.605 | -0.128 | -0.032 | -0.048 | -0.073 | -0.046 | -0.03 | -0.03 | -0.364 | -0.045 | -0.573 | -0.039 | 0 | -0.205 | -0.195 | -0.163 | -0.028 | -0.13 | -0.036 | -0.059 |
| EPS
| 0.63 | -0.32 | -0.15 | -0.16 | -0.27 | -0.12 | -0.091 | -0.22 | -2.26 | -0.27 | -3.71 | -0.25 | 1.83 | -0.46 | -0.43 | -0.37 | -0.058 | -0.25 | -0.063 | -0.11 |
| EPS Diluted
| 0.62 | -0.31 | -0.15 | -0.16 | -0.086 | -0.043 | -0.091 | -0.22 | -2.26 | -0.046 | -0.64 | -0.25 | 1.83 | -0.46 | -0.43 | -0.37 | -0.055 | -0.25 | -0.063 | -0.11 |
| EBITDA
| -96.209 | -79.135 | -0.677 | -21.739 | -41.66 | -11.154 | -1.725 | -26.532 | -505.308 | -40.765 | -878.652 | -36.277 | -183.76 | -27.667 | -25.541 | -12.656 | -4.099 | -13.269 | -4.474 | -5.951 |
| EBITDA Ratio
| -0.26 | -0.219 | -0.002 | -0.056 | -0.12 | -0.039 | -0.005 | -0.088 | -1.957 | -0.164 | -3.261 | -0.133 | -0 | -0.177 | -0.169 | -0.084 | -0.031 | -0.103 | -0.038 | -0.052 |